DarioHealth stockholders approve amendment to 2020 Equity Incentive Plan increasing share reserve

The stockholders elected the following directors of the Company to hold office until the next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal. The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis): Director Name For Against Abstain Broker Non-Votes Hila Karah 11,309,066 1,716,541 44,975 4,233,336 Dennis Matheis 11,319,813 1,710,588 40,181 4,233,336 Dennis M. McGrath 9,803,299 3,222,302 44,981 4,233,336 Erez Raphael 12,826,044 232,018 12,520 4,233,336 Yoav Shaked 11,310,152 1,741,869 18,561 4,233,336 Adam K. Stern 12,986,045 57,691 26,846 4,233,336

The stockholders approved the Plan Amendment. The Plan Amendment proposal required the affirmative vote of a majority of the votes cast at the 2022 Annual Meeting. The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis): For Against Abstain Broker Non-Votes 9,340,879 3,672,599 57,104 4,233,336

The stockholders ratified the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2022. The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis): For Against Abstain 15,380,546 1,919,212 4,160